IBI Scientific Advisory Board

Dr. Arnold N. Weinberg
A Professor of Medicine at Harvard and Senior Physician at Massachusetts General Hospital, Dr Weinberg has served the School and Hospital in a variety of capacities. At the Medical School, he was responsible for courses in microbiology, pathophysiology of infectious diseases and clinical infectious disease. At Massachusetts General Hospital, he was Vice Chair of Medicine, and, for over 4 decades, he has taught and consulted in general medicine and infectious disease. In addition, he served as Medical Director at Massachusetts Institute of Technology and continues to consult at MIT's Lincoln Laboratory and is a member of the Board of Directors at the Whitehead Institute for Biomedical Research. Dr Weinberg's publications include over 70 articles and text chapters on a wide range of infectious disease subjects.

Dr. David H. Gelfand
Dr. Gelfand most recently served as Vice President, Discovery Research at Roche Molecular Systems, Inc. (RMS). During nearly 14 years with RMS, Dr. Gelfand and his colleagues were responsible for the discovery, isolation, generation, biochemical characterization and applications of numerous thermophilic and hyperthermophilic DNA replication enzymes and other proteins for DNA amplification and automated DNA cycle sequencing. Dr. Gelfand and his colleagues discovered, characterized and applied the reverse transcriptase activity of thermophilic DNA polymerases for RT-PCR.

Prior to joining Roche Molecular Systems, Inc., Dr. Gelfand was with Cetus Corporation for over 15 years, where he founded the Recombinant Molecular Research Division in 1976. Dr. Gelfand has published more than 45 scientific papers and book chapters and is inventor or co-inventor of more than 45 issued U.S. patents, particularly in the area of PCR and thermostable DNA polymerases. In May 1990, he was honored in Washington, D.C. as “Distinguished Inventor” for his discovery of Taq DNA polymerase.

James W. Snyder, Ph.D.
James W. Snyder, Ph.D. is a professor in the Department of Pathology and Laboratory Medicine and Chief of Microbiology at the University of Louisville Hospital and Associate Faculty at the Center for Deterrence of Biowarfare and Bioterrorism. Dr. Snyder earned his Ph.D. in Biology (Medical Microbiology) from the University of Dayton. He has also been a Member of the Laboratory Response Network Working Group for Preparation and Response to Bioterrorism since 2000. His specialties include medical mycology, bioterrorism, and molecular diagnostics of infectious diseases with research focus on product and instrument evaluation.

Raymond Mackay, Ph.D.
Raymond Mackay, Ph.D., was a research associate at SUNY, in the Nuclear Engineering Department at Brookhaven National Laboratory, received a doctoral degree from SUNY Stony Brook, served as a Captain in the U.S. Army, and joined Drexel University in Philadelphia, Pennsylvania as a Professor of Chemistry. He then became Director of the New York State-sponsored Center for Advanced Materials Processing at Clarkson University and became the Director, Research and Technology, at the Edgewood Chemical Biological Center of the U.S. Army in 2003. An author / co-author of over 140 technical publications, he completed a 13-year tenure as an Associate Editor of the Journal of the American Oil Chemists' Society in 1997. His list of awards and honors, include the Meritorious Civilian Service Medal, the Army's second highest civilian honor and the Maryland Chemist of the Year award from the American Chemical Society. Recently, Dr. Mackay received the Exceptional Civilian Service Award, which is the highest civilian award in the Department of the Army. He is currently working for the Army (ECBC) in the capacity of science advisor.

Barry N. Kreiswirth, Ph.D.
Barry N. Kreiswirth, Ph.D. is Director of the TB Center at the Public Health Research Institute, New York and is a professor of medicine at the University of Medicine and Dentistry of New Jersey. Dr. Kreiswirth earned his Ph.D. in Microbiology from New York University. Two major areas of his research interests include Staphylococcal aureus and Mycobacterium tuberculosis. He has over 70 publications on the biology, molecular epidemiology, and antibiotic resistance of Staph aureus. Dr. Kreiswirth is on the editorial board of several major microbiology journals, and has chaired many prestigious conferences in the area of infectious diseases.